Weight Loss Doc Warns Of False Hope on New Weight Loss Drug

Share Article

Newly-revealed cholesterol drug GC-1 has been shown to have amazing weight loss benefits in mice, but weight loss expert Dr. Myo Nwe warns that this shouldn’t encourage people to try risky methods currently available. Human application is still years away says Dr. Myo Nwe of the Ace Medical Weight Loss Center.

Fat-Me-Not: Weight Loss Diet Of The Future

we don’t jar the stomach with foreign chemicals or herbs in an effort to change the body’s natural mechanics. It’s risky, can have some very adverse side effects, and on top of everything else it’s usually entirely unsustainable.”

After news from the 97th annual meeting of the Endocrine Society, also known as ENDO ’15, that a newly discovered drug effectively speeds up metabolism in mice, a weight loss expert is encouraging caution among those looking for a miracle cure for obesity.

“This new drug is called GC-1, and it shows a lot of hope,” says author and co-founder of the Ace Medical Weight Loss Center Dr. Myo Nwe, “but its application is still a decade away. Those trying to lose weight often hear about new advances on the distant horizon, and it can actually drive them toward risky diet plans or appetite suppressants on the market now. That’s dangerous.”

As widely reported earlier in March, GC-1 was revealed at the conference, and shown to reduce cholesterol levels and enhance the metabolism of obese mice, with some being genetically overweight and others whose obesity was “diet-induced.” There’s hope that similar results will be seen when a human trial beginning as early as next year, though successfully bringing the drug to the marketplace would likely take closer to a decade.

“People hear about a bold new drug or treatment, and it gets them hopeful about what’s actually available now. But that can be false hope,” Dr. Nwe explains.

Dr. Nwe previously authored the weight loss guide “Fat Me Not” to challenge many common myths of dieting, and also developed the Slimplate Weight Loss System which is designed to help dieters maintain proper portion control. She is a double board certified physician by American Board of Obesity Medicine and Internal Medicine, and practices in both the Carolinas.

“I always try to encourage tried-and-true methods or information, always rooted in science and our understanding of the human body,” she adds. “I’m especially suspect of the many varied appetite suppressants on the market currently. They tend to make a lot of wild promises.”

“We successfully adjust our appetites through gradual changes to our food intake, we don’t jar the stomach with foreign chemicals or herbs in an effort to change the body’s natural mechanics. It’s risky, can have some very adverse side effects, and on top of everything else it’s usually entirely unsustainable.”

Study author Dr. Kevin Price of the Houston Methodist Research Institute presented the findings on GC-1. Hundreds of mice were given the drug, which manipulates how sensitive the body is to insulin. Some mice saw as much as 50 percent loss of their fat mass in as little as two weeks.

GC-1 is currently being used in human trials for the purpose of lowering cholesterol only. Considerably higher dosages would need to be approved to see the drugs purported weight loss benefits, according to Dr. Price.

Nwe’s book “Fat Me Not” and portion control Slimplate Weight Loss System are available here.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sandeep Grewal
@SlimPlate
Follow >
SlimPlate
Like >
Follow us on
Visit website